Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Z Lorenc

Plastic Surgery New York, NY Medical Doctor

NPI 1417000845 CMS profile 245861

983 Park Ave, New York, NY 10028

Open in the dashboard

General payments

$224,548

137 records reported · program years 2019–2025

Research payments

$333,534

Paid to them · 15 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$172,500 paid to institutions, not to them · program year 2025

Through program year 2025, Z Lorenc of New York, NY is reported in the CMS Open Payments database as having received $224,548 across 137 general payments and $333,534 in research payments paid to them. Separately, studies naming them as principal investigator received $172,500 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $91,397 20
2024 General $24,552 13
2023 General $2,368 12
2022 General $48,565 38
2021 General $17,954 10
2021 Research $333,534 15
2020 General $24,141 14
2019 General $15,571 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Z Lorenc
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Z Lorenc were reported at $91,397. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Z Lorenc Plastic Surgery median Middle half National median
2019 $15,571 $371 $122–$1,483 $163
2020 $24,141 $158 $52–$438 $114
2021 $17,954 $249 $87–$752 $132
2022 $48,565 $274 $102–$793 $149
2023 $2,368 $299 $113–$891 $160
2024 $24,552 $361 $124–$1,062 $164
2025 $91,397 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Merz North America, Inc. $116,711 64 payments
  2. Galderma Laboratories, L.P. $52,274 31 payments
  3. IBSA Institut Biochimique SA $20,000 2 payments
  4. Krystal Biotech Inc $16,307 4 payments
  5. AbbVie, Inc. $13,108 22 payments
  6. Ipsen Innovation $3,515 2 payments
  7. Allergan Inc. $1,543 8 payments
  8. Endo Pharmaceuticals Inc. $940 1 payment
  9. Solta Medical, a division of Bausch Health US, LLC $111 2 payments
  10. Revance Therapeutics, Inc. $39 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $182,865 42 payments
  2. Travel and Lodging $28,032 37 payments
  3. Grant $10,000 1 payment
  4. Food and Beverage $3,650 57 payments
Products named General payments · program years 2019–2025
  1. Xeomin Dermatology $73,115 37 payments
  2. Xeomin musculoskeletal $17,500 13 payments
  3. DYSPORT $3,515 2 payments
  4. ASCLERA $263 7 payments
  5. DAXXIFY $39 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Merz North America, Inc. $333,534 15 payments

Records

152 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record